Reporting and registering nonmelanoma skin cancers: A compelling public health need

British Journal of Dermatology

Volumn 166, Issue 5, 2012, Pages 913-915

  Geller, A C ^a   Swetter, S M ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BASAL CELL CARCINOMA; CANCER CENTER; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHILDHOOD CANCER; EUROPE; GENERAL PRACTITIONER; HEALTH CARE ORGANIZATION; HISTOLOGY; HUMAN; NOTE; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; SKIN CANCER; SYSTEMATIC REVIEW (TOPIC); UNITED STATES;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; SKIN NEOPLASMS;

EID: 84860324654     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10911.x     Document Type: Note

References (15)

1. International Agency for Research on Cancer. Cancer Incidence, Mortality and Prevalence Worldwide in 2008. Globocan 2008. Lyons: IARC, 2012. Available at: (last accessed 23 February 2012).
2. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146: 283-7.
3. Cancer Council Australia. Skin cancer facts and figures. Available at: (last accessed 23 February 2012).
4. Morris S, Cox B, Bosanquet N,. Cost of skin cancer in England. Eur J Health Econ 2009; 10: 267-73.
5. Guy GP, Ekwueme DU,. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics 2011; 29: 863-74.
6. Tinghög G, Carlsson P, Synnerstad I, Rosdahl I,. Societal cost of skin cancer in Sweden in 2005. Acta Derm Venereol 2008; 88: 467-73.
7. Rigel DS, Friedman RJ, Kopf AW,. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol 1996; 35: 1012-13. (Pubitemid 26422139)
8. Karagas MR, Stannard VA, Mott LA,. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002; 94: 224-6. (Pubitemid 34162756)
9. Bakos RM, Kriz M, Mühlstädt M,. Risk factors for early-onset basal cell carcinoma in a German institution. Eur J Dermatol 2011; 21: 705-9.
10. Armstrong GT, Liu W, Leisenring W, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2011; 29: 3056-64.
11. Clowers-Webb HE, Christenson LJ, Phillips PK, et al. Educational outcomes regarding skin cancer in organ transplant recipients: randomized intervention of intensive vs standard education. Arch Dermatol 2006; 142: 712-18.
12. Lomas A, Leonardi-Bee J, Bath-Hextall F,. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166; 5: 1069-80.
13. Gordon LG, Scuffham PA, van der Pols JC, et al. Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings. J Invest Dermatol 2009; 129: 2766-71.
14. National Institute for Health and Clinical Excellence. Improving Outcomes for People with Skin Tumours Including Melanoma (Update): The Management of Low-Risk Basal Cell Carcinomas in the Community. London: NICE, 2010.
15. Wheless L, Black J, Alberg AJ,. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2010; 19: 1686-95.